Concepedia

Lyudmyla Berim

LB

9

Publications

1.2K

Citations

9

H-Index

2014

Active since

Affiliations

University of Nebraska Medical Center(Current)

Rutgers, The State University of New Jersey

Rutgers Cancer Institute

Stony Brook Medicine

Cornell University

Lyudmyla Berim is an author at University of Nebraska Medical Center specializing in medicine, cancer research, and tumor biology.

Top concepts

Publications per year

2014–2024

9

Publications

9

MUC1 and HIF-1alpha Signaling Crosstalk Induces Anabolic Glucose Metabolism to Impart Gemcitabine Resistance to Pancreatic Cancer

Surendra K. Shukla, Vinee Purohit, Kamiya Mehla et al. · Cancer Cell · 2017 · 531 citations · Full text

, , +7

Adenosine 2A Receptor Blockade as an Immunotherapy for Treatment-Refractory Renal Cell Cancer

Lawrence Fong, Andrew Hotson, John D. Powderly et al. · Cancer Discovery · 2019 · 321 citations · Full text

<i>De Novo</i> Lipid Synthesis Facilitates Gemcitabine Resistance through Endoplasmic Reticulum Stress in Pancreatic Cancer

Saber Tadros, Surendra K. Shukla, Ryan J. King et al. · Cancer Research · 2017 · 222 citations · Full text

Circulating tumor DNA (ctDNA) for informing adjuvant chemotherapy (ACT) in stage II/III colorectal cancer (CRC): Interim analysis of BESPOKE CRC study.

Pashtoon Murtaza Kasi, Vasily N. Aushev, Joe Ensor et al. · Journal of Clinical Oncology · 2024 · 54 citations

, , +23

The miR-487b-3p/GRM3/TGFβ signaling axis is an important regulator of colon cancer tumorigenesis

Hwalin Yi, Li Geng, Adrian R. Black et al. · Oncogene · 2017 · 42 citations · Full text

, , +11

Rows per page

1–5 of 9